CureVac (CVAC) shares were up 32% in recent Thursday premarket activity after the company and BioNTech (BNTX) said they signed an agreement under which BioNTech will acquire CureVac in an all-stock deal.
Liminatus Pharma (LIMN) stock was 26% higher, shaving Wednesday's loss.
Klotho Neurosciences (KLTO) shares were 19% higher, erasing the previous session's fall.
Oracle (ORCL) stock was 9% higher, a day after the company reported higher fiscal Q4 non-GAAP earnings and revenue.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.